Article

Cancer Treatment Advances Highlight Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/cancer-treatment-advances-highlight-specialty-phar" target="_blank">View the story "Cancer Treatment Advances Highlight Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Patient receiving cancer treatment infusion -- Image credit: UlrikaArt | stock.adobe.com
Small cell lung cancer -- Image credit: LASZLO | stock.adobe.com
Related Content
Exploring the Tumor Microenvironment Interactions Between Cancer Cells, TCells, and Nanoparticles in Cancer Therapy and Immunology
March 31st 2025

NCCN 2025: Managing Immune Checkpoint Inhibitor-Related Toxicities in Cancer Care

Luke Halpern, Assistant Editor
Pharmacy focus podcast
March 28th 2025

From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

Alexandra Gerlach, Associate Editor
Patient with an IV in their arm -- Image credit: sinhyu | stock.adobe.com
March 31st 2025

FDA Grants BA1302 Orphan Drug Designation for Squamous NSCLC and Pancreatic Cancer

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer
March 29th 2025

ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer

Aislinn Antrim, Managing Editor
a close-up of a lung with cancer cells and an overlay of a magnified section of a blood sample Generative AI
March 29th 2025

NCCN 2025: Immune Checkpoint Inhibitors Expand Treatment Options for Early-Stage NSCLC

Luke Halpern, Assistant Editor